| James H Peterson, MD | |
|
2528 W 16th St, Greeley, CO 80634-4955 | |
| (970) 356-4646 | |
| (970) 356-2041 |
| Full Name | James H Peterson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 2528 W 16th St, Greeley, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659338812 | NPI | - | NPPES |
| 01180355 | Medicaid | CO | |
| 2996978 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 18035 (Colorado) | Primary |
| 207Y00000X | Otolaryngology | 35089116 (Ohio) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| James H Peterson, MD 2528 W 16th St, Greeley, CO 80634-4955 Ph: (970) 356-4646 | James H Peterson, MD 2528 W 16th St, Greeley, CO 80634-4955 Ph: (970) 356-4646 |
News Archive
Dr. Julie Gerberding, director, Centers for Disease Control and Prevention ,speaking at the National Immunization Conference Washington, DC, says the rubella virus, a major cause of serious birth defects such as deafness and blindness, also known as congenital rubella syndrome (CRS) is no longer considered to be a major public health threat in the United States.
The Board of Directors of Healthcare Trust of America, Inc. (HTA) declared cash distributions for the months of October, November, and December 2009. These distributions will be calculated based on the stockholders of record each day during such month and will equal a 7.25% annualized rate based on a share price of $10.00.
A team of scientists including two physicists at the University of Sussex has found a way to circumvent a 178-year old theory which means they can effectively cancel magnetic fields at a distance.
Millennium Pharmaceuticals today announced, in collaboration with Johnson & Johnson Pharmaceutical Research & Development, LLC, the initiation of VISTA (Velcadeas Initial Standard Therapy in multiple myeloma: Assessment with melphalan and prednisone), a multicenter, international phase III clinical trial of Velcadein combination with melphalan and prednisone versus melphalan and prednisone in patients with newly diagnosed multiple myeloma (MM) who are not transplant candidates.
› Verified 5 days ago
Dr. Sanjay K Gupta, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6500 29th Street, Suite 106, Greeley, CO 80634 Phone: 970-330-5555 Fax: 970-584-1055 | |
Dr. Thomas T Peterson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5881 W 16th St, Greeley, CO 80634 Phone: 970-313-2740 Fax: 970-313-2744 | |
Dr. Thomas Maxwell Fissenden, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5881 W 16th St, Greeley, CO 80634 Phone: 970-313-2740 Fax: 970-313-2744 |